Urinary proteomic biomarkers to predict cardiovascular events

CKD273, a New Proteomics Classifier Assessing CKD and Its Prognosis

(2013) Àngel Argilés et al.   PLoS One

Proteasix: A tool for automated and large-scale prediction of proteases involved in naturally occurring peptide generation

(2013) Julie Klein et al.   PROTEOMICS

Clinical Implications of Adipocytokines and Newly Emerging Metabolic Factors with Relation to Insulin Resistance and Cardiovascular Health

(2013) Sung Hee Choi et al.   Frontiers in Endocrinology

A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus

(2012) S. S. Roscioni et al.   DIABETOLOGIA

Urinary proteome analysis in hypertensive patients with left ventricular diastolic dysfunction

(2012) T. Kuznetsova et al.   EUROPEAN HEART JOURNAL

Cardiovascular Risk Assessment in the 21st Century

(2012) J. Michael Gaziano et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Urinary Proteomics to Support Diagnosis of Stroke

(2012) Jesse Dawson et al.   PLoS One

Urinary Proteomics for Prediction of Preeclampsia

(2011) David M. Carty et al.   HYPERTENSION

Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT)

(2011) Ajay K. Gupta et al.   JOURNAL OF HYPERTENSION

Urinary proteomic diagnosis of coronary artery disease: identification and clinical validation in 623 individuals

(2010) Christian Delles et al.   JOURNAL OF HYPERTENSION

Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease

(2010) David M. Good et al.   MOLECULAR & CELLULAR PROTEOMICS

Circulating retinol-binding protein 4, cardiovascular risk factors and prevalent cardiovascular disease in elderly

(2009) Erik Ingelsson et al.   ATHEROSCLEROSIS

Criteria for Evaluation of Novel Markers of Cardiovascular Risk

(2009) Mark A. Hlatky et al.   CIRCULATION

Evaluation of Urinary Biomarkers for Coronary Artery Disease, Diabetes, and Diabetic Kidney Disease

(2009) Janet K. Snell-Bergeon et al.   Diabetes Technology & Therapeutics

Risk prediction is improved by adding markers of subclinical organ damage to SCORE

(2009) T. Sehestedt et al.   EUROPEAN HEART JOURNAL

CARDIOVASCULAR RISK ASSESSMENT THROUGH TARGET ORGAN DAMAGE: ROLE OF CAROTID TO FEMORAL PULSE WAVE VELOCITY

(2008) Pierre Boutouyrie et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Technical, bioinformatical and statistical aspects of liquid chromatography–mass spectrometry (LC–MS) and capillary electrophoresis-mass spectrometry (CE-MS) based clinical proteomics: A critical assessment☆

(2008) Mohammed Dakna et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Quantitative Urinary Proteome Analysis for Biomarker Evaluation in Chronic Kidney Disease

(2008) Justyna Jantos-Siwy et al.   JOURNAL OF PROTEOME RESEARCH

Urinary Proteomics in Diabetes and CKD

(2008) K. Rossing et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

The search for new cardiovascular biomarkers

(2008) Robert E. Gerszten et al.   NATURE